Cholestasis beyond the Neonatal and Infancy Periods

키워드

참고문헌 (51)

1. Suchy FJ, "Liver disease in children" (2014), Cambridge University Press
2. Kremer AE, "Advances in pathogenesis and management of pruritus in cholestasis", Dig Dis, 32, pp.637~645 (2014)
3. Chappell LC, "Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial", BMJ, 344, pp.e3799~ (2012)
4. Kronsten V, "Management of cholestatic pruritus in paediatric patients with alagille syndrome: the King's College Hospital experience", J Pediatr Gastroenterol Nutr, 57, pp.149~154 (2013)
5. Moyer V, "Guideline for the evaluation of cholestatic jaundice in infants: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition", J Pediatr Gastroenterol Nutr, 39, pp.115~128 (2004)
6. Nathanson MH, "Mechanisms and regulation of bile secretion", Hepatology, 14, pp.551~566 (1991)
7. Keely SJ, "Bile acid-induced secretion in polarized monolayers of T84 colonic epithelial cells: Structure- activity relationships", Am J Physiol Gastrointest Liver Physiol, 292, pp.G290~G297 (2007)
8. Wagner M, "New molecular insights into the mechanisms of cholestasis", J Hepatol, 51, pp.565~580 (2009)
9. Trauner M, "Molecular pathogenesis of cholestasis", N Engl J Med, 339, pp.1217~1227 (1998)
10. Stringer MD, "Gallstone composition: are children different", J Pediatr, 142, pp.435~440 (2003)
11. Friesen CA, "Cholelithiasis. Clinical characteristics in children. Case analysis and literature review", Clin Pediatr (Phila), 28, pp.294~298 (1989)
12. Katsika D, "Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs", Hepatology, 41, pp.1138~1143 (2005)
13. O'Neill JA Jr, "Choledochal cyst", Curr Probl Surg, 29, pp.361~410 (1992)
14. Shah OJ, "Choledochal cysts in children and adults with contrasting profiles: 11-year experience at a tertiary care center in Kashmir", World J Surg, 33, pp.2403~2411 (2009)
15. Singham J, "Choledochal cysts: part 2 of 3: Diagnosis", Can J Surg, 52, pp.506~511 (2009)
16. Panagiotakaki E, "Genotype-phenotype correlations for a wide spectrum of mutations in the Wilson disease gene (ATP7B)", Am J Med Genet A, 131, pp.168~173 (2004)
17. Beasley RP, "Rocks along the road to the control of HBV and HCC", Ann Epidemiol, 19, pp.231~234 (2009)
18. Schilsky ML, "Genetic testing for Wilson disease: availability and utility", Curr Gastroenterol Rep, 12, pp.57~61 (2010)
19. Ranucci G, "Wilson disease: what is still unclear in pediatric patients", Clin Res Hepatol Gastroenterol, 38, pp.268~272 (2014)
20. Srivastava A, "Progressive familial intrahepatic cholestasis", J Clin Exp Hepatol, 4, pp.25~36 (2014)
21. Jacquemin E, "Progressive familial intrahepatic cholestasis", Clin Res Hepatol Gastroenterol, 36(Suppl 1), pp.S26~S35 (2012)
22. Jansen PL, "Progressive familial intrahepatic cholestasis types 1, 2, and 3", Gut, 42, pp.766~767 (1998)
23. Alagille D, "L'atresie des voies biliaires intrahepatiques avec voies biliaires extrahepatiques permeables chez l'enfant", pp.301~318 (1969), Flammarion
24. Kamath BM, "Consequences of JAG1 mutations", J Med Genet, 40, pp.891~895 (2003)
25. Davis AR, "Interpreting conjugated bilirubin levels in newborns", J Pediatr, 158, pp.562~565.e1 (2011)
26. Weiss JS, "clinical importance of a protein- bound fraction of serum bilirubin in patients with hyperbilirubinemia", N Engl J Med, 309, pp.147~150 (1983)
27. Harb R, "Conjugated hyperbilirubinemia: screening and treatment in older infants and children", Pediatr Rev, 28, pp.83~91 (2007)
28. Ovchinsky N, "Liver biopsy in modern clinical practice: a pediatric point-of-view", Adv Anat Pathol, 19, pp.250~262 (2012)
29. Bucuvalas JC, "Resistance to the growth-promoting and metabolic effects of growth hormone in children with chronic liver disease", J Pediatr, 117, pp.397~402 (1990)
30. de Albuquerque Taveira AT, "Impairment of bone mass development in children with chronic cholestatic liver disease", Clin Endocrinol, 66, pp.518~523 (2007)
31. Brumbaugh D, "Conjugated hyperbilirubinemia in children", Pediatr Rev, 33, pp.291~302 (2012)
32. Keil R, "Diagnostic efficacy of ERCP in cholestatic infants and neonates--a retrospective study on a large series", Endoscopy, 42, pp.121~126 (2010)
33. Bhavsar MS, "Choledochal cysts : a review of literature", Saudi J Gastroenterol, 18, pp.230~236 (2012)
34. Lewis VA, "Imaging of choledochal cysts", Abdom Imaging, 40, pp.1567~1580 (2015)
35. Cai Q, "Intraduodenal hydrochloric acid infusion for facilitation of cannulation of the dorsal pancreatic duct at ERCP in patients with pancreas divisum: a preliminary study", Am J Gastroenterol, 105, pp.1450~1451 (2010)
36. Ahrar H, "Magnetic resonance cholangiography compared with endoscopic retrograde cholangiography in the diagnosis of primary sclerosing cholangitis", J Res Med Sci, 19, pp.1150~1154 (2014)
37. Moff SL, "Diagnosis of primary sclerosing cholangitis: a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography", Gastrointest Endosc, 64, pp.219~223 (2006)
38. Feldstein AE, "Primary sclerosing cholangitis in children: a long-term follow-up study", Hepatology, 38, pp.210~217 (2003)
39. Eppens EF, "FIC1, the protein affected in two forms of hereditary cholestasis, is localized in the cholangiocyte and the canalicular membrane of the hepatocyte", J Hepatol, 35, pp.436~443 (2001)
40. European Association for Study of Liver, "EASL Clinical Practice Guidelines: Wilson's disease", J Hepatol, 56, pp.671~685 (2012)
41. Navarro VJ, "Drug-related hepatotoxicity", N Engl J Med, 354, pp.731~739 (2006)
42. Hegade VS, "Drug treatment of pruritus in liver diseases", Clin Med (Lond), 15, pp.351~357 (2015)
43. Chang Y, "The use of naltrexone in the management of severe generalized pruritus in biliary atresia: report of a case", Pediatr Dermatol, 25, pp.403~404 (2008)
44. Ständer S, "Neurophysiology of pruritus: cutaneous elicitation of itch", Arch Dermatol, 139, pp.1463~1470 (2003)
45. Browning J, "Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis", Am J Gastroenterol, 98, pp.2736~2741 (2003)
46. Müller C, "Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial", Eur J Gastroenterol Hepatol, 10, pp.865~870 (1998)
47. Nightingale S, "Optimizing nutritional management in children with chronic liver disease", Pediatr Clin North Am, 56, pp.1161~1183 (2009)
48. Mager DR, "Branched-chain amino acid needs in children with mild-to-moderate chronic cholestatic liver disease", J Nutr, 136, pp.133~139 (2006)
49. Shneider BL, "Childhood Liver Disease Research Education Network (ChiLDREN). Efficacy of fat-soluble vitamin supplementation in infants with biliary atresia", Pediatrics, 130, pp.e607~e614 (2012)
50. Shen YM, "Oral absorbable fat-soluble vitamin formulation in pediatric patients with cholestasis", J Pediatr Gastroenterol Nutr, 55, pp.587~591 (2012)
51. Jensen M, "Difficulty achieving vitamin D sufficiency with high-dose oral repletion therapy in infants with cholestasis", J Pediatr Gastroenterol Nutr, 61, pp.187~189 (2015)

관련 논문AI추천